Company / Debt per Share
RIGEL PHARMACEUTICALS INC Debt per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$2.96
FY2025
5-year range
$0.12 / $3.43
FY2021-FY2025
Trend
-13.6%
vs FY2024
Sector context
#35 of 82
Health Care
What the data says
At $2.96, RIGEL PHARMACEUTICALS INC's debt per share ranks #48 of 82 in the Health Care sector. Debt per Share has fluctuated over the past 7 years, ranging from $0.06 in FY2019 to $3.43 in FY2024.
Based on SEC 10-K filings.
2.96 in FY2025 with a 5-year CAGR of +90.2%.
Increased from $0.35 to $2.96 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +133.4%
- 5-Year CAGR
- +90.2%
- 10-Year CAGR
- -
Sector benchmark
#48 of 82 in Health CareTop 57% of 82This company $2.96 Sector average $126.59
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 13.6% year-over-year.
- Ranks #35 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2024.
- Lowest debt per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.96 | -13.6% |
| FY2024 | $3.43 | +891.8% |
| FY2023 | $0.35 | +48.4% |
| FY2022 | $0.23 | +97.3% |
| FY2021 | $0.12 | -0.8% |
| FY2020 | $0.12 | +99.0% |
| FY2019 | $0.06 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026